Innovative Stem Cell Therapy Improves Lives

More than 11 million people suffer from chronic obstructive pulmonary disease or COPD in America. This disease and other chronic lung diseases can be debilitating and life altering. However, there is hope with a groundbreaking stem cell therapy being used at the Lung Institute. The Lung Institute has been on the forefront of stem cell therapy for chronic lung disease since it’s founding in 2013.

Over the last decade, there has been a lot of controversy about the ethics of stem cell therapy. Lost in all of the noise about embryonic stem cells was the fact that everyone has stem cells. Using autologous stem cells which are derived from the patient’s own body, has proven to be a very promising form of therapy. The Lung Institute has capitalized on this and devised a unique and non-invasive therapy.

The stem cells are derived from the patient’s blood or bone marrow, harvested, and returned to the patient’s blood stream. According to, while some stem cell treatments are highly experimental, the Lung Institute’s therapies have been used on over one thousand patients who have seen noticable improvement in their pulmonary health and have been able to start enjoying their lives again.

The treatment that is being pioneered by the Lung Institute is groundbreaking because they can be done without being invasive. There is a mechanism inside the lungs known as the pulmonary trap. Stem cells that are injected into the blood stream are very quickly pushed into the lungs. Where the normal blood cells pass through the lungs, the stem cells become stuck. The body then uses the cells to start repairing the damaged lungs.

The Lung Institute has seen success in treating pulmonary fibrosis, COPD, chronic bronchitis, interstitial lung disease, and emphysema. With as little as one blood draw and one injection patients who used to be in constant pain can start to enjoy life again. Contact us!